ID

22139

Description

Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00466284

Lien

https://clinicaltrials.gov/show/NCT00466284

Mots-clés

Versions (1)
  1. 21/05/2017 21/05/2017 -
Téléchargé le

21 mai 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Non-Small Cell Lung Cancer NCT00466284

Anglais

Eligibility Non-Small Cell Lung Cancer NCT00466284

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 18 years.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
patients must have histologically confirmed diagnosis of non-small cell lung cancer, which is not surgically resectable (stage ia- iiib).
Description

Non-Small Cell Lung Carcinoma unresectable TNM clinical staging

Type de données

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C1519810
UMLS CUI [1,3]
C3258246
measurable disease.
Description

Measurable Disease

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
written informed consent must be obtained prior to the inclusion into the trial.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
karnofsky performance status of 80%.
Description

Karnofsky Performance Status

Type de données

boolean

Alias
UMLS CUI [1]
C0206065
patients must have been treated with no prior chemotherapy or radioterapy.
Description

Prior Chemotherapy Absent | Prior radiation therapy Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0279134
UMLS CUI [2,2]
C0332197
patients must have adequate bone marrow, liver and renal function.
Description

Bone Marrow function | Liver function | Renal function

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
bone marrow: wbc > 3000 x 103/mm3,
Description

Bone Marrow function | White Blood Cell Count procedure

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0023508
platelets > 100 x 103/mm3,
Description

Platelet Count measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0032181
hgb > 10.0 gm/dl,
Description

Hemoglobin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0518015
anc >1500 x 103/mm3,
Description

Absolute neutrophil count

Type de données

boolean

Alias
UMLS CUI [1]
C0948762
hepatic:bilirubin < 2 mg/dl (34 µmol/l); ast, alt, and alkaline phosphatase < 5 x normal,
Description

Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201899
UMLS CUI [4]
C0201836
UMLS CUI [5]
C0201850
renal:creatinine < 1.5 mg/dl (132 µmol/l).
Description

Renal function | Creatinine measurement, serum

Type de données

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
female patients who are pregnant or lactating.
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients who have used other investigational agents within 21 days prior to study entry.
Description

Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C0013230
patients who have received prior treatment with erlotinib or other anti-egfr agent.
Description

erlotinib | Epidermal growth factor receptor inhibitor

Type de données

boolean

Alias
UMLS CUI [1]
C1135135
UMLS CUI [2]
C1443775
significant comorbidity.
Description

Comorbidity Significant

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0750502
Retour au début de la page

Similar models

Eligibility Non-Small Cell Lung Cancer NCT00466284

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 18 years.
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma unresectable TNM clinical staging
Item
patients must have histologically confirmed diagnosis of non-small cell lung cancer, which is not surgically resectable (stage ia- iiib).
boolean
C0007131 (UMLS CUI [1,1])
C1519810 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
Measurable Disease
Item
measurable disease.
boolean
C1513041 (UMLS CUI [1])
Informed Consent
Item
written informed consent must be obtained prior to the inclusion into the trial.
boolean
C0021430 (UMLS CUI [1])
Karnofsky Performance Status
Item
karnofsky performance status of 80%.
boolean
C0206065 (UMLS CUI [1])
Prior Chemotherapy Absent | Prior radiation therapy Absent
Item
patients must have been treated with no prior chemotherapy or radioterapy.
boolean
C1514457 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0279134 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Bone Marrow function | Liver function | Renal function
Item
patients must have adequate bone marrow, liver and renal function.
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Bone Marrow function | White Blood Cell Count procedure
Item
bone marrow: wbc > 3000 x 103/mm3,
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0023508 (UMLS CUI [2])
Platelet Count measurement
Item
platelets > 100 x 103/mm3,
boolean
C0032181 (UMLS CUI [1])
Hemoglobin measurement
Item
hgb > 10.0 gm/dl,
boolean
C0518015 (UMLS CUI [1])
Absolute neutrophil count
Item
anc >1500 x 103/mm3,
boolean
C0948762 (UMLS CUI [1])
Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement
Item
hepatic:bilirubin < 2 mg/dl (34 µmol/l); ast, alt, and alkaline phosphatase < 5 x normal,
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0201850 (UMLS CUI [5])
Renal function | Creatinine measurement, serum
Item
renal:creatinine < 1.5 mg/dl (132 µmol/l).
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
female patients who are pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Investigational New Drugs
Item
patients who have used other investigational agents within 21 days prior to study entry.
boolean
C0013230 (UMLS CUI [1])
erlotinib | Epidermal growth factor receptor inhibitor
Item
patients who have received prior treatment with erlotinib or other anti-egfr agent.
boolean
C1135135 (UMLS CUI [1])
C1443775 (UMLS CUI [2])
Comorbidity Significant
Item
significant comorbidity.
boolean
C0009488 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial